Time to Hematopoietic Recovery
| . | Gene Rx Patients (n = 6) . | Non-Gene Rx Patients (n = 13) . |
|---|---|---|
| Median days (±SD) to granulocytes >500/μL | 11 ± 0.9 | 10 ± 0.4 |
| Median days (±SD) to granulocytes >1,200/μL | 12.5 ± 0.8 | 11 ± 0.8 |
| Median days (±SD) to platelets >20,000/μL | 14.5 ± 2.7 | 12 ± 1.5 |
| Median (±SD) CD34+ cells reinfused (×106/kg) | 1.4 ± 0.4 | 2.4 ± 0.3 |
| . | Gene Rx Patients (n = 6) . | Non-Gene Rx Patients (n = 13) . |
|---|---|---|
| Median days (±SD) to granulocytes >500/μL | 11 ± 0.9 | 10 ± 0.4 |
| Median days (±SD) to granulocytes >1,200/μL | 12.5 ± 0.8 | 11 ± 0.8 |
| Median days (±SD) to platelets >20,000/μL | 14.5 ± 2.7 | 12 ± 1.5 |
| Median (±SD) CD34+ cells reinfused (×106/kg) | 1.4 ± 0.4 | 2.4 ± 0.3 |
Abbreviation: Rx, therapy.